生命科学资讯

The Zacks Analyst Blog Highlights Walmart, Wells Fargo, Thermo Fisher Scientific, Seneca Foods and NetSol Technologies - Zacks Investment Research

Ipsen gains access to ADC from Shanghai biotech Simcere Zaiming

10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus

10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus

Radiopharmaceutical specialist Aktis seeks an IPO

Illumina (NASDAQ:ILMN) Price Target Raised to $130.00 - MarketBeat

10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat

Boehringer taps Rectify to create pills for chronic kidney disease

Biopharma CEO optimism is wavering in the U.S.

Laekna Pharmaceutical divulges new PI3Kα inhibitors

Aché Laboratórios Farmacêuticos describes new SGLT-1, SGLT-2 and DPP4 inhibitors

New TEAD inhibitors disclosed in Signet Therapeutics patent

Jiangsu Simcere Biologics discovers new bispecific ADCs

Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? - Nasdaq

AstraZeneca bets up to $2B on Jacobio’s pan-KRAS inhibitor for cancer

AstraZeneca fronts $100M for Jacobio's clinical-stage pan-KRAS inhibitor

AstraZeneca flunks phase 3 lung cancer test in further setback to synthetic lethal mechanism

Wasatch Biolabs announces co-marketing agreement with Agilent to advance native-read targeted sequencing - News-Medical

AGILENT TECHNOLOGIES, INC. SEC 10-K Report - TradingView — Track All Markets

Agilent Technologies : Annual Report for Fiscal Year Ending October 31, 2025 (Form 10-K) - marketscreener.com